1. Home
  2. CBAN vs CDXS Comparison

CBAN vs CDXS Comparison

Compare CBAN & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBAN
  • CDXS
  • Stock Information
  • Founded
  • CBAN 1975
  • CDXS 2002
  • Country
  • CBAN United States
  • CDXS United States
  • Employees
  • CBAN N/A
  • CDXS N/A
  • Industry
  • CBAN Major Banks
  • CDXS Major Chemicals
  • Sector
  • CBAN Finance
  • CDXS Industrials
  • Exchange
  • CBAN Nasdaq
  • CDXS Nasdaq
  • Market Cap
  • CBAN 309.0M
  • CDXS 332.0M
  • IPO Year
  • CBAN 1998
  • CDXS 2010
  • Fundamental
  • Price
  • CBAN $16.22
  • CDXS $5.63
  • Analyst Decision
  • CBAN
  • CDXS Buy
  • Analyst Count
  • CBAN 0
  • CDXS 2
  • Target Price
  • CBAN N/A
  • CDXS $11.00
  • AVG Volume (30 Days)
  • CBAN 37.2K
  • CDXS 705.8K
  • Earning Date
  • CBAN 01-22-2025
  • CDXS 10-31-2024
  • Dividend Yield
  • CBAN 2.63%
  • CDXS N/A
  • EPS Growth
  • CBAN 1.70
  • CDXS N/A
  • EPS
  • CBAN 1.25
  • CDXS N/A
  • Revenue
  • CBAN $108,949,000.00
  • CDXS $64,446,000.00
  • Revenue This Year
  • CBAN N/A
  • CDXS N/A
  • Revenue Next Year
  • CBAN $6.05
  • CDXS $2.02
  • P/E Ratio
  • CBAN $12.93
  • CDXS N/A
  • Revenue Growth
  • CBAN N/A
  • CDXS N/A
  • 52 Week Low
  • CBAN $10.33
  • CDXS $2.53
  • 52 Week High
  • CBAN $18.49
  • CDXS $6.08
  • Technical
  • Relative Strength Index (RSI)
  • CBAN 33.09
  • CDXS 71.90
  • Support Level
  • CBAN $17.15
  • CDXS $5.42
  • Resistance Level
  • CBAN $17.87
  • CDXS $6.01
  • Average True Range (ATR)
  • CBAN 0.48
  • CDXS 0.33
  • MACD
  • CBAN -0.18
  • CDXS 0.03
  • Stochastic Oscillator
  • CBAN 4.62
  • CDXS 69.68

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division, and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

About CDXS Codexis Inc.

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.

Share on Social Networks: